National Bank of Canada’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.8M | Buy |
2,069,698
+866,964
| +72% | +$40.1M | 0.09% | 167 |
|
|
2025
Q1 | $73.4M | Sell |
1,202,734
-1,422,275
| -54% | -$86.7M | 0.08% | 203 |
|
|
2024
Q4 | $148M | Buy |
2,625,009
+118,268
| +5% | +$6.69M | 0.16% | 102 |
|
|
2024
Q3 | $130M | Buy |
2,506,741
+1,656,141
| +195% | +$85.7M | 0.15% | 117 |
|
|
2024
Q2 | $35.1M | Buy |
850,600
+123,938
| +17% | +$5.11M | 0.05% | 236 |
|
|
2024
Q1 | $32.6M | Sell |
726,662
-2,100,837
| -74% | -$94.4M | 0.05% | 239 |
|
|
2023
Q4 | $149M | Buy |
2,827,499
+1,326,387
| +88% | +$70M | 0.24% | 83 |
|
|
2023
Q3 | $86.7M | Buy |
1,501,112
+183,517
| +14% | +$10.6M | 0.13% | 121 |
|
|
2023
Q2 | $84.7M | Buy |
1,317,595
+383,589
| +41% | +$24.7M | 0.16% | 117 |
|
|
2023
Q1 | $64.8M | Sell |
934,006
-187,940
| -17% | -$13M | 0.16% | 108 |
|
|
2022
Q4 | $80.7M | Buy |
1,121,946
+824,324
| +277% | +$59.3M | 0.21% | 89 |
|
|
2022
Q3 | $21.1M | Sell |
297,622
-75,006
| -20% | -$5.31M | 0.11% | 191 |
|
|
2022
Q2 | $28.7M | Buy |
372,628
+127,640
| +52% | +$9.83M | 0.13% | 142 |
|
|
2022
Q1 | $18M | Sell |
244,988
-125,237
| -34% | -$9.18M | 0.05% | 240 |
|
|
2021
Q4 | $23.1M | Buy |
+370,225
| New | +$23.1M | 0.08% | 178 |
|